Entering text into the input field will update the search result below

Premarket Gainers as of 9:05 am

Nov. 09, 2017 9:24 AM ETBy: Gaurav Batavia, SA News Editor
  • OTIC +114% on Q3 result.
  • CALL +50%.
  • KBSF +49%.
  • SAGE +46% on late-stage success with brexanolone propels Marinus Pharma.
  • CVO +42% on $61M U.S. Census contract award.
  • ROKU +29% on Q3 result.
  • ARLZ +20% on Q3 result.
  • MRNS +20% on late-stage success with brexanolone propels Marinus Pharma.
  • UEC +18%.
  • OSTK +15% on Q3 result.
  • COTY +14% on Q3 result.
  • PRTY +12% on Q3 result.
  • KNDI +12% on Q result.
  • PRGO +12% on Q3 result.
  • SEDG +11%.
  • NQ +8% on the FL Mobile divestment and the sale of Showself's live social video business.
  • NOG +8% on Q3 result.
  • ODP +7% on Q3 result.
  • IOVA +7% on early efficacy and safety data from Cohort 2 of the ongoing Phase 2 LN-144 metastatic melanoma trial.
  • GOOS +6% on Q3 result.
  • SMI +6%.
  • EVOK +5% on signing commercial agreement with Thermo Fisher Scientific.

Recommended For You

More Trending News